ALEMBIC LIMITED (ALEMBICLTD) financials

ALEMBIC LIMITED (ALEMBICLTD) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered…

  • Market Cap: ₹2,496Cr.
  • Current Price: ₹97.4
  • Stock P/E: 20.4
  • ROE: 14.2%
  • ROCE: 16.9%
  • Book Value: ₹32.0
  • Dividend Yield: 2.47%
  • 52W High / Low: ₹118/70.5

In Jun 2026, ALEMBIC LIMITED (ALEMBICLTD) reported sales ₹46 Cr and net profit ₹15 Cr.

Annual TTM: sales ₹230 Cr, net profit ₹122 Cr.

Shareholding: Promoters 71.40% (Sep 2026), FIIs 1.34% (Sep 2026), DIIs 0.05% (Sep 2026), Public 27.20% (Sep 2026), No. of Shareholders 1,00,706% (Sep 2026).

ALEMBICLTD quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales5156584854725846
Expenses3330322932453832
Operating Profit1826261923272014
OPM %36%46%45%39%42%37%34%30%
Other Income6643365226
Interest11000000
Depreciation33333333
Profit before tax8127261984251816
Tax %5%4%11%10%10%12%48%7%
Net Profit7726231776221015
EPS in Rs2.981.000.890.672.950.870.370.57
Raw PDF————————
ALEMBICLTD profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales747276123152214232230
Expenses7062638596125144147
Operating Profit411133856908883
OPM %5%15%17%31%37%42%38%36%
Other Income9310895455757375
Interest00001222
Depreciation34467101213
Profit before tax94179785103152147144
Tax %0%19%12%7%10%7%15%—
Net Profit9413867993142125122
EPS in Rs3.640.523.343.093.625.534.854.76
Dividend Payout %16%38%54%71%66%43%49%—
ALEMBICLTD balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital5151515151515151
Reserves361432775962778757802770
Borrowings-0-00-0-091411
Other Liabilities5751109130119128142126
Total Liabilities4705349361,1449489461,010958
Fixed Assets209225261294318366406470
CWIP-036001-02
Investments205197581726503411414349
Other Assets5510988124127168190138
Total Assets4705349361,1449489461,010958
ALEMBICLTD cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity225-1-22352581117
Cash from Investing Activity6857-35231123-22-52
Cash from Financing Activity-89-6-15-6-46-48-58-67
Net Cash Flow156-52-5-002-1
Free Cash Flow-1-16-44-5510-313041
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit145%187%8%-102%108%42%107%156%
ALEMBICLTD shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters70.88%70.88%70.88%70.88%70.88%70.88%70.88%71.40%
FIIs1.78%1.65%1.50%1.38%1.29%1.25%1.25%1.34%
DIIs0.06%0.05%0.05%0.05%0.05%0.05%0.06%0.05%
Public27.27%27.41%27.57%27.68%27.78%27.81%27.82%27.20%
No. of Shareholders1,07,4231,06,7321,07,5101,06,4701,04,1031,02,0081,01,2381,00,706
ALEMBICLTD key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4044667267424748
Inventory Days2894112,1122,8855,1183,694—1,161
Days Payable2021516756359931,213—510
Cash Conversion Cycle1263041,5042,3224,1912,52347698
Working Capital Days1328962311277558-2
ROCE %10%21%2%10%10%12%18%17%
ALEMBICLTDUpdated 17 Oct 2026, 2:16

Alembic Limited

Market Cap

₹2,496Cr.

Current Price

₹97.4

High / Low

₹118/70.5

Stock P/E

20.4

ROE14.2%
ROCE16.9%
Book Value₹32.0
Face Value₹2.00
Dividend Yield2.47%

About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1227654744044667267424748
Inventory Days8806594382472894112,1122,8855,1183,694—1,161
Days Payable2001441281252021516756359931,213—510
Cash Conversion Cycle8015913641951263041,5042,3224,1912,52347698
Working Capital Days23517239201328962311277558-2
ROCE %9%8%8%10%10%21%2%10%10%12%18%17%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ALEMBIC LIMITED (ALEMBICLTD)?

The reported market capitalisation for ALEMBIC LIMITED (ALEMBICLTD) is ₹2,496Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ALEMBICLTD?

The current price shown for ALEMBIC LIMITED (ALEMBICLTD) on Fincrux is ₹97.4 with a 52-week high/low of ₹118/70.5.

What is the P/E ratio of ALEMBIC LIMITED (ALEMBICLTD)?

The stock P/E for ALEMBIC LIMITED (ALEMBICLTD) is 20.4 on Fincrux, with ROE at 14.2% and ROCE at 16.9%.

What were ALEMBICLTD latest quarterly results?

For Jun 2026, ALEMBIC LIMITED (ALEMBICLTD) reported sales ₹46 Cr and net profit ₹15 Cr (figures in ₹ crore unless noted).

What are ALEMBICLTD annual sales and net profit?

For TTM, ALEMBIC LIMITED (ALEMBICLTD) shows sales of ₹230 Cr and net profit of ₹122 Cr on the Fincrux profit & loss statement.

Who owns ALEMBIC LIMITED (ALEMBICLTD)?

Latest shareholding for ALEMBIC LIMITED (ALEMBICLTD) on Fincrux: Promoters 71.40% (Sep 2026), FIIs 1.34% (Sep 2026), DIIs 0.05% (Sep 2026), Public 27.20% (Sep 2026), No. of Shareholders 1,00,706% (Sep 2026).

Where can I find ALEMBIC LIMITED (ALEMBICLTD) financials?

ALEMBIC LIMITED (ALEMBICLTD) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ALEMBICLTD balance sheet and cash flow?

Yes. The ALEMBIC LIMITED (ALEMBICLTD) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 October 2026 at 2:16


Designed & Shipped by Harshit Bansal